Closed meeting: Pooled safety data and, where applicable, efficacy data are verified with the student statistician(s) available for consultation during this meeting. Pooled data should be presented after coded processing arms. As a general rule, only members with the right to vote participate in this meeting. Only members of the DSMB participate in this last meeting to ensure full objectivity when discussing the results, making decisions and making recommendations for the study. Where processing codes have been made available to the DSMB, the DSMB may unmask the data based on predefined procedures. Members of the Data and Safety Monitoring Board (DSMB) are selected by NIEHS to reflect the medical disciplines and specialties needed to interpret data from the above studies. All DSMB members must be completely independent of the verified studies and all members must sign a DSMB conflict of interest statement and privacy statement. The DSMB should finalize any review with its recommendations to the NIDCR on the continuation, modification or termination of the study without modification. Recommendations for design modification and conduct of the study could include: the Data and Safety Monitoring Board (DSMB) is an independent expert group to advise the NIDCR. DSMB members serve in their individual capacity and provide their expertise and recommendations. The main tasks of the DSMB are to: 1) regularly verify and evaluate the safety, implementation and progress of the participants and, where appropriate, evaluate their effectiveness, and 2) make recommendations to the NIDCR for the continuation, modification or completion of the study. The DSMB takes into account study-specific data as well as relevant basic knowledge about the disease being studied, the tester or the patient population.
The participation of DSMB members generally takes place during the duration of the study. Participation in permanent DSMBs convened for the follow-up of several protocols or long-term studies can be done under fixed conditions. Since the continuity of the revision is essential, the duration of the fixed deadlines should be modulated so as not to alter more than one third of the accession at the same time. Confidentiality should always be maintained at all stages of DSMB verification and advice. As a general rule, only members with voting rights of the DSMB should have access to interim analyses of outcome data by processing group. Exemptions may be granted if the DSMB deems it appropriate. The reason for and exceptions to access to intermediate scans are recorded in the closed session report. Members of the DSMB must remain strictly confidential for all preferred results of studies provided to them. The DSMB should only verify the data after masked study groups (e.g. B X vs. Y instead of an experimental check or until the DSMB finds that the group identifiers are necessary for decision making.
When hidden data is presented to the DSMB, the group encoding key must be available for instant unmasking. Has. Report on open meetings: This report contains information on the conduct of studies, as described in point III above, for example. B delimitation, appropriate demographic presentation, basic characteristics, protocol compliance, location performance, quality control and timeliness of monitoring. General (unassed) adverse reactions and toxicity issues are also included in the open report. Has. Open meeting: issues related to the overall conduct and progress of the study are addressed, including adverse events and toxicity issues, delineation, demographic characteristics of participants as a whole, disease status of participants (if applicable), comparability of groups with respect to baseline factors, compliance with the report, location performance, quality control and timeliness and completeness of follow-up. . . .